U.S. Supreme Court rejects Bristol Myers cancer-drug patent fight with Gilead:
reuters.com/legal/us-supreme-court-rejects-bristol-myers-cancer-drug-patent-fight-with-gilead-2022-11-07/
Story Details
| Last Updated | Nov 07 22 |
| Total Articles | 3 |
More articles on this subject
Previous
Swiss pharma giant Roche's first-quarter sales edge higher as its emerges from post-Covid-19 slump
cnbc.com/2024/04/24/swiss-pharma-giant-roches-first-quarter-sales-edge-higher-as-its-emerges-from-post-covid-19-slump.html
Blackstone nears deal to sell S.Korean pharma wholesaler to MBK Partners, sources say
reut.rs/3U84zcy
Nuclear medicine is big pharma's new target in cancer race: Biotechs work on injected radioactive drugs to target tumors
gulfnews.com/lifestyle/health-fitness/nuclear-medicine-is-big-pharmas-new-target-in-cancer-race-1.1712928209636
Weight-loss drug startup Metsera wants to take on Novo and Lilly. Here’s what you need to know
fastcompany.com/91110090/metsera-startup-eli-lilly-novo-nordisk-competitor-weight-loss-drugs
Drugmakers' low U.S. taxes belie their high sales: Most of the largest pharmaceutical companies report losing money in the United States ...
npr.org/sections/health-shots/2024/04/15/1244876740/drugmakers-low-taxes-us
Recall of 'Benylin' drug batch occasioned by contamination concerns: Benylin recall serves as a stark reminder of the importance of stringent quality ...
standardmedia.co.ke/health/health-science/article/2001493198/recall-of-benylin-drug-batch-occasioned-by-contamination-concerns
Drug distributor Cardinal Health to lose OptumRx contracts: Cardinal Health said on Monday its contracts with UnitedHealth Group's OptumRx ...
reuters.com/business/healthcare-pharmaceuticals/cardinal-health-says-contracts-with-unitedhealths-optumrx-will-not-be-renewed-2024-04-22/
Corona is long gone - Now the pharmaceutical giant Roche has also survived the aftermath
diepresse.com/18399963/corona-ist-lange-passe-nun-hat-auch-der-pharma-riese-roche-die-nachwehen-ueberstanden
Irish-founded Nutriband raises millions in fresh funding: Company intends to file for FDA approval for its proprietary abuse-deterrent technology
businesspost.ie/news/irish-founded-nutriband-raises-millions-in-fresh-funding/
Paid articlePaid
Pharma exports rise around 10% to $27.9 billion, US biggest importer: The country's drugs and pharmaceuticals exports increased 9.67 per cent year-on-year to USD ...
business-standard.com/industry/news/pharma-exports-rise-around-10-to-27-9-billion-us-biggest-importer-124042400568_1.html
How drug prices are negotiated in Switzerland and beyond - SWI swissinfo.ch: Switzerland's pharmaceutical sector supplies drugs worldwide ...
swissinfo.ch/eng/multinational-companies/who-decides-drug-prices-and-how/75914703
Bosnian police arrest 23 suspected of being part of drug lord's circle: The world-notorious kingpin was arrested in 2022 and ultimately sentenced to seven ...
euronews.com/2024/04/23/police-in-bosnia-arrest-23-suspected-members-of-drug-kingpins-inner-circle
The federal government wants to improve the framework conditions for the pharmaceutical industry
dlvr.it/T5vT2T
Xarelto®: First generics on sale: The patent for Xarelto® has expired and rivaroxaban generics have been listed in the Lauer tax for the first time since April ...
ptaheute.de/aktuelles/2024/04/23/xarelto-r-erste-generika-im-handel
MBK Partners acquires pharmaceutical wholesaler Geo-Young from Blackstone: MBK Partners has acquired a major stake in pharmaceutical wholesaler Geo-Young ...
koreatimes.co.kr/www/biz/2024/04/175_373212.html
Bangladesh produces biologic drug in milestone achievement : Experts hoped that the new drug would enrich the local pharmaceutical industry further if there is ...
en.prothomalo.com/bangladesh/8i0mm8moxu
Körber is now expanding: a new building is scheduled to be built by 2026: Construction work on the new building for Körber Pharma Packaging AG in the Grabs ...
wundo.ch/artikel/koerber-baut-jetzt-aus-bis-2026-soll-ein-neubau-entstehen/
Paid articlePaid
Low-carb diets work. Why does the American Diabetes Association push insulin instead?
theguardian.com/commentisfree/2024/apr/17/ada-american-diabetes-association-big-pharma
French Greens’ top candidate wants 'European pharmaceutical sovereignty': Marie Toussaint, the lead of the French Greens' campaign for the June European ...
euractiv.com/section/health-consumers/news/french-greens-top-candidate-wants-european-pharmaceutical-sovereignty/
The quiet heroes behind the electoral bonds stories: Reporters who file daily stories are the ones who make the big stories possible
thehindu.com/opinion/op-ed/the-quiet-heroes-behind-the-electoral-bonds-stories/article68079093.ece
Inside Novartis' Outsized Play In India - Forbes India: Forbes India's Manu Balachandran talks about Vasant 'Vas' Narasimhan, CEO, Novartis ...
forbesindia.com/audio/audio/inside-novartis-outsized-play-in-india/92631
Meet Premchand Godha, the man who transformed a struggling company into a Rs 28,000 crore pharma giant with Amitabh Bachchan
financialexpress.com/web-stories/lifestyle/meet-premchand-godha-the-man-who-transformed-a-struggling-company-into-a-rs-28000-crore-pharma-giant-with-amitabh-bachchan-2/
Qureight has raised $8.5 million for its AI techbio platform: AI techbio startup Qureight makes it easier for pharma companies to conduct clinical trials.
businessinsider.com/qureight-has-raised-8-5-million-ai-techbio-platform-2024-4
U.S. Scrutiny of Chinese Company Could Disrupt U.S. Supply Chain for Key Drugs: Lawmakers raising national security concerns and seeking to disconnect a major ...
nytimes.com/2024/04/15/health/wuxi-us-drugs-congress.html
Serum Institute, Univercells tie-up for affordable personalised cancer care: SII was the world’s largest vaccine manufacturer with a global footprint of any ...
financialexpress.com/healthcare/news-healthcare/serum-institute-univercells-tie-up-for-affordable-personalised-cancer-care/3456066/
Several aces up his sleeve: Is this well-known pharmaceutical share currently available at a super savings price?
boerse-online.de/nachrichten/aktien/gleich-mehrere-asse-im-aermel-gibt-es-diese-bekannte-pharma-aktie-jetzt-gerade-zum-super-sparpreis-20355267.html
JPMorgan Hires Health-Care Banker Dass from Deutsche Bank: JPMorgan Chase & Co. has hired health-care banker Christopher Dass from Deutsche Bank AG as a ...
bloomberg.com/news/articles/2024-04-15/jpmorgan-hires-health-care-banker-dass-from-deutsche-bank
Paid articlePaid Novartis: Innovating For The World, From India - Forbes India: How Vasant 'Vas' Narasimhan is readying India to play a bigger role in its medicines ...
forbesindia.com/article/leadership/novartis-innovating-for-the-world-from-india/92575/1
EU partners Nigeria to boost local vaccine production: The European funding, allocated under the Team Europe Initiative on Manufacturing and Access to Vaccines ...
punchng.com/eu-partners-nigeria-to-boost-local-vaccine-production/
Kara Swisher calls out urgent need for AI guardrails: Famed journalist and author Kara Swisher joined TheStreet to discuss the pressing need for AI regulations ...
star-telegram.com/news/business/article287655870.html
Paid articlePaid
Bridging the pharma-business gap: AS most of Malaysia’s pharmaceutical and cosmetic products are imported, it is crucial that we expand the capabilities of our ...
thestar.com.my/news/education/2024/04/14/bridging-the-pharma-business-gap
AstraZeneca’s Pascal Soriot ‘massively underpaid’ at £16.9mn, says top shareholder
ft.com/content/c7226781-b45b-4502-ba38-129dea5e960e
Sales rumors! Is this biotech company changing hands soon?: Janux Therapeutics considers sale following takeover interest.
deraktionaer.de/artikel/pharma-biotech/verkaufsgeruechte-wechselt-diese-biotech-firma-bald-den-besitzer-20355065.html
Sweden aims to keep current data protection period in EU pharma package: The Swedish government is opposed to shortening the regulatory data protection period ...
euractiv.com/section/health-consumers/news/sweden-aims-to-keep-current-data-protection-period-in-eu-pharma-package/
Belgium’s university-industry collaboration model could accelerate EU's advanced therapeutics
euractiv.com/section/health-consumers/news/belgiums-university-industry-collaboration-model-could-accelerate-eus-advanced-therapeutics/
Big Pharma Stocks Need a Rethink. Investors Keep Making the Same Mistake.: Pfizer’s patent expirations are great for humanity but terrible for investors ...
barrons.com/articles/big-pharma-stocks-investors-mistakes-90e3c575
Paid articlePaid ENVI's EU pharma package 'a bloody compromise' says Czech shadow rapporteur: EP votes on Wednesday (10 April) on the new pharmaceutical legislation ...
dlvr.it/T5HDbC
Germany's factory orders back to growth in February: New orders in manufacturing up 0.2% month-on-month in February, shifting from January's 11.4% decline ...
yenisafak.com/en/news/germanys-factory-orders-back-to-growth-in-february-3680756
Paid articlePaid US takes next step in Medicare drug price negotiations with pharma companies: The Biden administration said on Tuesday it has responded to offers from the ...
reuters.com/business/healthcare-pharmaceuticals/us-takes-next-step-medicare-drug-price-negotiations-with-pharma-companies-2024-04-02/
Biden summons Bernie Sanders to help boost drug-price campaign: The president is hoping the Vermont senator can help tap into popular frustrations against ...
washingtonpost.com/health/2024/04/03/biden-sanders-drug-prices/
RFK Jr names wealthy lawyer, 'warrior mom' Shanahan as running mate: Independent U.S. presidential candidate Robert F. Kennedy Jr. on Tuesday picked wealthy ...
reuters.com/world/us/robert-f-kennedy-jr-name-vice-presidential-pick-tuesday-2024-us-election-bid-2024-03-26/
Quick Glance: RFK Jr. selects attorney Nicole Shanahan as his VP candidate
- Independent presidential hopeful, Robert F. Kennedy Jr., revealed on Tuesday that Nicole Shanahan, a wealthy attorney and entrepreneur in the San Francisco Bay Area, is joining his campaign as his vice presidential candidate.
- Shanahan has been actively contributing to Kennedy's campaign and his super PAC, solidifying her position as a potential vice presidential candidate.
- Additionally, Shanahan has established a foundation advocating for issues such as reproductive longevity and equality, criminal justice reform, and a sustainable planet.
- Kennedy has a strong emphasis on anti-vaccine efforts and has incorporated anti-vaccine activists into his campaign team to bolster his stance on the matter.
Century Health, now with $2M, taps AI to give pharma access to good patient data: Century Health is applying AI to clinical data to uncover new applications for ...
techcrunch.com/2024/03/27/century-health-2m-ai-pharma-patient-data/
Toxic food supplements: Japanese pharmaceutical company raided after deaths: Five people are said to have died in Japan after taking a cholesterol-lowering drug ...
spiegel.de/panorama/japan-razzia-bei-pharma-unternehmen-nach-todesfaellen-durch-cholesterinsenker-a-95c32e32-b40e-4aa4-960d-7a757644fc3d
Cholesterol-lowering drug scandal: Authorities search Japanese pharmaceutical factory
n-tv.de/wirtschaft/Behoerden-durchsuchen-japanische-Pharma-Fabrik-article24841189.html
Nvidia's AI ambitions in medicine and health care are becoming clear: Applying Nvidia AI chips to health care, whether it's biotechnology, chemicals ...
cnbc.com/2024/03/24/nvidias-ai-ambitions-in-medicine-and-health-care-are-becoming-clear.html
Johnson & Johnson is reportedly eyeing its second big heart device company acquisition
qz.com/johnson-and-johnson-shockwave-medical-1851367580
Paid articlePaid
Big business bristles at USTR reporting change on trade: The U.S. trade representative (USTR) is changing its definition of barriers to trade in its annual ...
thehill.com/business/4563984-big-business-bristles-at-ustr-reporting-change-on-trade/
What's at stake in the Supreme Court mifepristone case: The case could affect not just abortion access but oversight of the drug industry and the authority of ...
npr.org/sections/health-shots/2024/03/25/1240282129/mifepristone-supreme-court-fda-medication-abortion-explainer
EU parliament to extend new medicine data protection to 7.5 years, document says: EU lawmakers have gone part of the way to meeting pharmaceutical industry ...
reuters.com/world/europe/eu-parliament-extend-new-medicine-data-protection-75-years-document-says-2024-03-13/
From IVF to birth control, Supreme Court abortion pill case could spark challenges to other drugs
nbcnews.com/politics/supreme-court/ivf-birth-control-supreme-court-abortion-pill-case-spark-challenges-dr-rcna144435
The battle over the trillion-dollar weight-loss bonanza: Novo Nordisk and Eli Lilly are making blockbuster drugs. Can they maintain their lead?
econ.st/3Vb1RFg
A frenzy of innovation in obesity drugs is under way: Novo Nordisk and Eli Lilly are printing money now. But they will not be a stagnant duopoly
economist.com/leaders/2024/03/07/a-frenzy-of-innovation-in-obesity-drugs-is-under-way
Paid articlePaid Ozempic maker Novo Nordisk gets more weight loss drug competition as a rival releases promising data
qz.com/viking-therapeutics-weight-loss-pill-ozempic-wegovy-1851366359
Paid articlePaid
Spin-off from Aspirin & Co.: sedative pill from the Bayer boss: The new CEO Bill Anderson is against a split of the pharmaceutical company and agrochemical ...
faz.net/aktuell/wirtschaft/unternehmen/kommentar-zur-aufspaltungsdiskussion-beruhigungspille-vom-bayer-chef-19564622.html
US judge upholds Medicare drug price negotiation program: A federal judge in Delaware on Friday upheld a law that requires some drugmakers to negotiate prices ...
reuters.com/legal/second-judge-upholds-medicare-drug-price-negotiation-program-2024-03-01/
Big Pharma is “coming to the table” on price negotiations as it loses in court: Negotiating prices is not a "gun to the head," judge rules.
arstechnica.com/science/2024/03/big-pharma-is-coming-to-the-table-on-price-negotiations-as-it-loses-in-court/
हेल्थकेयर फंड्स ने 1 साल में दिया 50 से 60% रिटर्न, इतना मुनाफा देने वाली स्कीम के बारे में जानें सब कुछ
hindi.financialexpress.com/investment-saving-news/healthcare-mutual-funds-gives-upto-60pc-return-in-one-year-who-should-and-why-invest-in-these-schemes-4387408
Bayer calls off breakup of company 'for now' after huge loss: German chemical and pharmaceutical giant Bayer pledged Tuesday to 'urgently' address key challenges ...
dailysabah.com/business/economy/bayer-calls-off-breakup-of-company-for-now-after-huge-loss
Four killed, over 10 injured in explosion at pharma plant in Telangana
deccanherald.com/india/telangana/four-killed-over-10-injured-in-explosion-at-pharma-plant-in-telangana-2963891
Time to Spring Clean Your Medicine Cabinet. What Are Must-Haves and What Can Be Tossed?
slate.com/podcasts/well-now/2024/04/spring-cleaning-your-medicine-cabinet
Charleston pharma exec and cousin admit to illicit pandemic-driven stock trades: A former Charleston pharma executive and a relative pleaded guilty to insider ...
postandcourier.com/business/charleston-richmond-insider-trading-south-carolina-virginia/article_a2c579fa-f1e6-11ee-9b23-c3df0d7a106d.html
2nd Kobayashi Pharma factory inspected over deaths linked to dietary supplements: Health authorities searched a second Kobayashi Pharmaceutical factory in ...
japantoday.com/category/national/a-second-kobayashi-pharma-japan-factory-inspected-over-deaths
PM meets pharma heads and unionists: Prime Minister Kyriakos Mitsotakis hosted on Wednesday the heads of companies and unions that are members of the ...
ekathimerini.com/economy/1235513/pm-meets-pharma-heads-and-unionists/
How Big Pharma is fighting Biden’s program to lower seniors’ drug costs: Drug companies have tried to invalidate a program that would reduce the price of ...
washingtonpost.com/business/2024/03/11/pharma-drug-priding-biden-negotiations/
Suspect in the murder of the pharma CEO arrested in QC: One of the suspects in the murder of pharmaceutical company CEO Eduardo Tolosa Jr. was arrested ...
news.abs-cbn.com/news/2024/4/3/suspek-sa-pagpatay-ng-pharma-ceo-arestado-sa-qc-743
Data analytics can play a crucial role in connecting the right patient with right drugs: Jaswinder Chadha, President & CEO, Axtria
financialexpress.com/healthcare/pharma-healthcare/data-analytics-can-play-a-crucial-role-in-connecting-the-right-patient-with-right-drugs-jaswinder-chadha-president-ceo-axtria/3442724/
Limited innovation and profitability driving slow motion AMR crisis, Piot calls for action
euractiv.com/section/health-consumers/news/limited-innovation-and-profitability-driving-slow-motion-amr-crisis-piot-calls-for-urgent-action/
HBR On Strategy: The Key to Preserving a Long-Term Competitive Advantage on Apple Podcasts
podcasts.apple.com/us/podcast/the-key-to-preserving-a-long-term-competitive-advantage/id1683845677
6 pharmaceutical stocks that will soon rise, according to UBS analysts: UBS has analyzed the impact rebates can have on share prices in the pharmaceutical ...
businessinsider.de/wirtschaft/finanzen/bis-zu-120-prozent-wachstum-diese-6-pharma-aktien-solltet-ihr-kaufen-laut-ubs-analysten/
From biotech to techbio: these are the pharma plans of the AI partners of Bayer, Merck and Co.
handelsblatt.com/unternehmen/industrie/von-biotech-zu-techbio-diese-pharma-plaene-haben-die-ki-partner-von-bayer-merck-und-co/100025611.html
Sanders calls for Novo Nordisk to slash Ozempic, Wegovy prices: Sen. Bernie Sanders (I-Vt.) called on pharmaceutical manufacturer Novo Nordisk to slash prices ...
thehill.com/policy/healthcare/4560323-sanders-calls-for-novo-nordisk-slash-ozempic-wegovy-prices/
Readers’ comments: Good investigation, revoke licence of pharma companies that failed drug tests
scroll.in/article/1065673/readers-comments-good-investigation-revoke-licence-of-pharma-companies-that-failed-drug-tests
Daily Brief: Of Rs 945 crore bonds donated by drug firms, most went to parties ruling states with pharma units, and more
scroll-newsletter.stck.me/post/214675/Daily-Brief-Of-Rs-945-crore-bonds-donated-by-drug-firms-most-went-to-parties-ruling-states-with-pharma-units-and-more
Chinese pharma giant pumps $350m into dormant Irish entity: Wuxi AppTec was recently named as a ‘company of concern’ by US lawmakers over alleged links to the ...
businesspost.ie/news/chinese-pharma-giant-pumps-350m-into-dormant-irish-entity/
Paid articlePaid
India pharma quality lapses force U.S. to look to China for vital drugs: In the final weeks of 2022, a small team of inspectors from the U.S ...
asia.nikkei.com/Spotlight/Special-Reports/India-pharma-quality-lapses-force-U.S.-to-look-to-China-for-vital-drugs
Pharma investment: courage is rewarded: The Mainz-based mRNA pioneer Biontech is a good example of how it can be worth taking risks in the volatile ...
faz.net/aktuell/wirtschaft/unternehmen/biontech-mut-wird-belohnt-19600734.html
Paid articlePaidQuick Glance: BioNTech Focuses on Cancer Drug Development after Revenue Plunge
- BioNTech reported a significant drop in revenue and earnings in 2023 as it shifts focus towards cancer drug development.
- The company aims for revenues between 2.5 billion to 3.1 billion euros in 2024.
- BioNTech plans to launch its first oncology drug in 2026 and secure ten indication approvals by 2030.
- Partner Pfizer anticipates a decline in sales for the COVID-19 vaccine, while BioNTech invests in scaling up its oncology business.
FG to sign executive order to curb rising drug prices: The Coordinating Minister of Health and Social Welfare, Prof Muhammad Pate on Wednesday ...
punchng.com/fg-to-sign-executive-order-to-curb-rising-drug-prices/
Danish economy gets boost from weight-loss drug maker: The Danish economy grew 1.9 percent last
year but would have flatlined without its pharmaceutical ...
thelocal.dk/20240327/danish-economy-gets-boost-from-weight-loss-drug-maker
Closing bell: Nasdaq loses - Rumors about Cytokinetics and Shockwave Medical, Tesla accelerates
deraktionaer.de/artikel/maerkte-forex-zinsen/schlussglocke-nasdaq-verliert-geruechte-um-cytokinetics-und-shockwave-medical-tesla-gibt-gas-20353835.html
The weight loss drug race has Amgen coming for Novo Nordisk and Eli Lilly: Amgen is testing whether its new drug, a potential competitor to Novo Nordisk's hugely ...
qz.com/amgen-novo-nordisk-eli-lilly-wegovy-zepbound-1851361723
Paid articlePaid Next
New to NewsWall?
Sign up now to get your own personalized news!
Trending topics